Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Maha Radhakrishnan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kush Parmar - $3.65M in TRDA purchases and sales in the last 12 months
- MPM BioVentures 2014, L.P. - $3.60M in TRDA purchases and sales in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $3.60M in TRDA purchases and sales in the last 12 months
- Paul Peter Tak - $3.16M in CADL purchases and sales in the last 12 months
- Paul B. Manning - $3.00M in CADL purchases and sales in the last 12 months
- 5AM Ventures V, L.P. - $3.00M in TRDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Maha Radhakrishnan?
Maha Radhakrishnan is a corporate insider of Candel Therapeutics, Inc. (CADL). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Maha Radhakrishnan last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 2 filings going back to 2026.
